Mebutizide is a sulfonylurea anti-diabetic medication used to treat type 2 diabetes. It works by stimulating the pancreas to produce more insulin. It is typically taken once or twice a day with meals. Common side effects include nausea, vomiting, diarrhea, and headache. It can also cause hypoglycemia (low blood sugar).
tant to understand that Mebutizide is not a commonly prescribed medication today. Safer and more effective alternatives are generally preferred due to several reasons:
- Potential side effects: Mebutizide can cause electrolyte imbalances, particularly potassium deficiency, which can lead to serious health risks.
- Availability of safer alternatives: There are various diuretics with a better safety profile and similar effectiveness in managing high blood pressure.
Anatomical Therapeutic Chemical Classification
C - Cardiovascular system
C03 Diuretics
C03A - Low-ceiling diuretics, thiazides
C03AA Thiazides, plain
ATC Code
Anatomical Therapeutic Chemical Classification
C - Cardiovascular system
C03 Diuretics
C03E - Diuretics and potassium-sparing agents in combination
C03EA Low-ceiling diuretics and potassium-sparing agents
ATC Code
External Links
Mebutizide